Genome engineering technologies, such as Zinc finger nucleases (ZFNs), TAL effector nucleases (TALENs), and clustered regularly interspaced short palindromic repeats (CRISPR)-associated (Cas) nucleases (CRISPR/Cas), have widely used in life science and medical science. We are developing novel genome editing tools to overcome technical and patent limitation of CRISPR-Cas9 system. We are also developing the efficient genome editing strategies with these tools in rodents. These technologies facilitate easy and flexible gene editing in living organisms.
Division of Genome Engineering
|Location||General Research Building 2F|